{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:52:49Z","timestamp":1782755569343,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["2016ZX10002008-007"],"award-info":[{"award-number":["2016ZX10002008-007"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.bbrc.2017.09.156","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T13:32:35Z","timestamp":1506691955000},"page":"1396-1401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Thymosin \u03b24 attenuates liver fibrosis via suppressing Notch signaling"],"prefix":"10.1016","volume":"493","author":[{"given":"Yuheng","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2017.09.156_bib1","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: a translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2017.09.156_bib2","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jhep.2015.02.039","article-title":"Hepatic fibrosis: concept to treatment","volume":"62","author":"Trautwein","year":"2015","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.bbrc.2017.09.156_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2017.09.156_bib4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","article-title":"Evolving challenges in hepatic fibrosis","volume":"7","author":"Friedman","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2017.09.156_bib5","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/cphy.c120035","article-title":"Hepatic stellate cells and liver fibrosis","volume":"3","author":"Puche","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.bbrc.2017.09.156_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0036-1571295","article-title":"Antifibrotic therapies: where are we now?","volume":"36","author":"Yoon","year":"2016","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbrc.2017.09.156_bib7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1159\/000374098","article-title":"Hepatic fibrosis: emerging therapies","volume":"33","author":"Friedman","year":"2015","journal-title":"Dig. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.bbrc.2017.09.156_bib8","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1517\/14712598.2015.1011617","article-title":"Advances in the basic and clinical applications of thymosin beta 4","volume":"15","author":"Goldstein","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.bbrc.2017.09.156_bib9","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.17219\/acem\/32026","article-title":"Thymosin beta as an actin-binding protein with a variety of functions","volume":"25","author":"Kuzan","year":"2016","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.bbrc.2017.09.156_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1517\/14712598.2012.634793","article-title":"Thymosin beta4: a multi-functional regenerative peptide. Basic properties and clinical applications","volume":"12","author":"Goldstein","year":"2012","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.bbrc.2017.09.156_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1749-6632.2012.06752.x","article-title":"Thymosin beta4 and cardiac protection: implication in inflammation and fibrosis","volume":"1269","author":"Gupta","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbrc.2017.09.156_bib12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3748\/wjg.v16.i5.625","article-title":"Serum thymosin beta4 levels in patients with hepatitis B virus-related liver failure","volume":"16","author":"Han","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2017.09.156_bib13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.clinre.2014.02.004","article-title":"Thymosinbeta4: a novel assessed biomarker of the prognosis of acute-on-chronic liver failure patient?","volume":"38","author":"Liu","year":"2014","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.bbrc.2017.09.156_bib14","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000363005","article-title":"Depletion of thymosin \u03b24 promotes the proliferation, migration, and activation of human hepatic stellate cells","volume":"34","author":"Xiao","year":"2014","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.bbrc.2017.09.156_bib15","doi-asserted-by":"crossref","first-page":"30029","DOI":"10.1038\/srep30029","article-title":"omega-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP\/TAZ degradation","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2017.09.156_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41467-017-00204-4","article-title":"The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFbeta and Notch pathways","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2017.09.156_bib17","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/j.bbadis.2017.05.014","article-title":"BAG-1M co-activates BACE1 transcription through NF-kappaB and accelerates Abeta production and memory deficit in Alzheimer's disease mouse model","volume":"1863","author":"Shi","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2017.09.156_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-0035-1550060","article-title":"Emerging and disease-specific mechanisms of hepatic stellate cell activation","volume":"35","author":"Wallace","year":"2015","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbrc.2017.09.156_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best. Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.bbrc.2017.09.156_bib20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/gut.2005.088690","article-title":"Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis","volume":"56","author":"Inagaki","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2017.09.156_bib21","first-page":"57","article-title":"TGF-beta\/Smad signaling in the injured liver","volume":"44","author":"Breitkopf","year":"2006","journal-title":"Z\u00a0Gastroenterol."},{"key":"10.1016\/j.bbrc.2017.09.156_bib22","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.27720","article-title":"Strategies and endpoints of antifibrotic drug trials: summary and recommendations from the AASLD emerging trends conference, chicago, june 2014","volume":"62","author":"Torok","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2017.09.156_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/hep.1840030118","article-title":"Is cirrhosis of the liver experimentally produced by CCl4 and adequate model of human cirrhosis?","volume":"3","author":"Perez Tamayo","year":"1983","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2017.09.156_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1731937X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1731937X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T06:33:39Z","timestamp":1535351619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X1731937X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0006291X1731937X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.09.156","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thymosin \u03b24 attenuates liver fibrosis via suppressing Notch signaling","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.09.156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}